Cargando…
Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
Alzheimer’s disease (AD) has traditionally been discussed as a disease where serious cognitive decline is a result of Aβ-plaque accumulation, tau tangle formation, and neurodegeneration. Recently, it has been shown that metabolic dysregulation observed with insulin resistance and type-2 diabetes act...
Autores principales: | Yang, Alex J. T., Bagit, Ahmed, MacPherson, Rebecca E. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125227/ https://www.ncbi.nlm.nih.gov/pubmed/33924876 http://dx.doi.org/10.3390/ijms22094628 |
Ejemplares similares
-
Therapeutic potential of resveratrol in Alzheimer's disease
por: Vingtdeux, Valérie, et al.
Publicado: (2008) -
Beneficial effects of combined resveratrol and metformin therapy in treating diet‐induced insulin resistance
por: Frendo‐Cumbo, Scott, et al.
Publicado: (2016) -
Calpain Dysregulation in Alzheimer's Disease
por: Ferreira, Adriana
Publicado: (2012) -
Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
por: Yan, Xu, et al.
Publicado: (2020) -
Dysregulation of Iron Metabolism in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
por: Oshiro, Satoru, et al.
Publicado: (2011)